Newsroom
November 30, 2020
Venclose Corporate Overview Presentation Piper Sandler Healthcare Conference
View PresentationDecember 6, 2019
Venclose brings in $27 million Series C to market venous reflux solution
MedCity News
View ArticleApril 1, 2019
A New RF System: Venclose’s new radiofrequency technology outperforms legacy systems
Vein Therapy News
View ArticleJanuary 30, 2019
Venclose and Viant Partner to Deliver Next-Generation Vein Treatment Solutions
View Press ReleaseJuly 11, 2018
Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors
View Press ReleaseMarch 19, 2018